Polar Asset Management Partners’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Polar Asset Management Partners’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-150,000	Closed	-$1.48M	–	1468
2021 Q2	$1.48M	Hold	150,000	–	–	0.02%	588
2021 Q1	$1.45M	Buy	+150,000	New	+$1.45M	0.01%	519

Other funds holding PEAR

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return

RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Polar Asset Management Partners's PEAR Position: Q3 2021 in Review

Polar Asset Management Partners sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q3 2021, closing a stake of 150,000 shares — an estimated $1.48M sold.

Polar Asset Management Partners first reported a position in PEAR in Q1 2021 and held it in 2 quarters. The position peaked at $1.48M in Q2 2021. 85 funds tracked by Wall St. Rank hold PEAR as of Q3 2021.

Polar Asset Management Partners reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Polar Asset Management Partners sold 150,000 Pear Therapeutics, Inc. Class A Common Stock shares in Q3 2021, an estimated $1.48M.
Polar Asset Management Partners first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q1 2021 and held it in 2 quarters.
Polar Asset Management Partners's Pear Therapeutics, Inc. Class A Common Stock position peaked at $1.48M in Q2 2021.
85 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.